In this presentation, we explore why gene therapy must learn from its past to unlock its future. Drawing on decades of experience in viral vector development, the talk examines the growing reliance on high-dose AAV therapies, the safety and commercial challenges this creates, and why potency—not dose—should be the central focus of next-generation gene therapy Read More The post Why learning from past mistakes is more important than ever appeared first on Ascend .